Detalhe da pesquisa
1.
Hypothalamic-Pituitary-Adrenal Axis Response in Patients With Acne Vulgaris Treated With Clascoterone.
J Drugs Dermatol
; 23(6): 433-437, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38834220
2.
Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne Vulgaris.
J Drugs Dermatol
; 23(1): 1278-1283, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38206145
3.
Long-Term Safety and Efficacy of Twice-Daily Topical Clascoterone Cream 1% in Patients Greater Than or Equal to 12 Years of Age With Acne Vulgaris.
J Drugs Dermatol
; 22(8): 810-816, 2023 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556524
4.
Efficacy and Safety of 1% Clascoterone Cream in Patients Aged > 12 Years With Acne Vulgaris.
J Drugs Dermatol
; 22(2): 174-181, 2023 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36745367
5.
Evaluating Use of the Octreotide Acetate Pen Injector in a Summative Human Factors Validation Study.
Endocr Pract
; 28(4): 414-419, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123070
6.
Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis.
BMC Cancer
; 21(1): 1244, 2021 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34798846
7.
The effect of sonidegib (LDE225) on the pharmacokinetics of bupropion and warfarin in patients with advanced solid tumours.
Br J Clin Pharmacol
; 87(3): 1291-1302, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32736411
8.
A Review of Hedgehog Inhibitors Sonidegib and Vismodegib for Treatment of Advanced Basal Cell Carcinoma.
J Drugs Dermatol
; 20(2): 156-165, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538567
9.
Comment on "Basal cell carcinoma: Contemporary approaches to diagnosis, treatment, and prevention".
J Am Acad Dermatol
; 88(1): e29-e30, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31394136
10.
Notes & Comments on "Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and analysis".
J Am Acad Dermatol
; 86(4): e155-e156, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31078606
11.
Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes With LDE225 Treatment (BOLT) trial at 42 months.
J Am Acad Dermatol
; 84(4): 1162-1164, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33358380
12.
Is There a Clinically Relevant Risk of Hyperkalemia with Topical Clascoterone Treatment?
J Clin Aesthet Dermatol
; 16(6): 20-24, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37361363
13.
Concomitant medication use does not appear to alter long-term efficacy of sonidegib for advanced basal cell carcinoma: a post hoc analysis based on the 42-month BOLT study.
Eur J Dermatol
; 33(3): 280-286, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37594336
14.
Treatment Satisfaction and Acceptability of 20% Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses of the Face, Scalp, and Upper Extremities.
J Clin Aesthet Dermatol
; 16(12): 46-51, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38125671
15.
Halobetasol propionate lotion 0.05% in patients 12 to 16 years 11 months of age with plaque psoriasis: Results of an open-label study evaluating adrenal suppression potential.
JAAD Int
; 6: 13-19, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34870246
16.
Evaluation of the Octreotide Acetate Pen Injector and its Instructions for Use in a Formative Human Factors Study.
Adv Ther
; 38(6): 3129-3142, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33948925
17.
Effects of Sonidegib Following Dose Reduction and Treatment Interruption in Patients with Advanced Basal Cell Carcinoma During 42-Month BOLT Trial.
Dermatol Ther (Heidelb)
; 11(6): 2225-2234, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34669179
18.
Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysis.
Dermatol Ther (Heidelb)
; 11(5): 1839-1849, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34490549
19.
Expression of Glioma-associated oncogene homolog 1 as biomarker with sonidegib in advanced basal cell carcinoma.
Oncotarget
; 11(37): 3473-3483, 2020 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32973971
20.
Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks.
JAAD Int
; 10: 31-33, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36425794